Plain-English translation of NCT06859164 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This pilot study is testing a procedure called Genicular Artery Embolization (GAE) for people with knee osteoarthritis pain that hasn't improved with standard treatments like medications, physical therapy, or injections. The procedure uses imaging to locate small blood vessels supplying the inflamed tissue in the knee, then temporarily blocks them using a special emulsion to reduce pain. Researchers want to see if this treatment works better than a sham procedure (where patients receive the same preparation but no actual treatment) at reducing knee pain over three months.
Many people with knee osteoarthritis continue to suffer despite trying conservative treatments, and some aren't candidates for or don't want knee replacement surgery. This trial exists to determine whether this minimally invasive procedure could offer meaningful pain relief for these patients and to gather information needed to design a larger, more definitive study.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to either receive the actual procedure or a sham procedure (where you go through the same preparation but don't receive the treatment—this helps researchers know if the procedure itself works, not just the expectation of treatment). Either way, you'll have imaging tests and catheter placement in your leg. The main study visit involves this procedure, and researchers will follow up with you at 3 months to measure how much your knee pain has improved using standardized pain questionnaires. The study will also examine how your mental health, medications, and knee imaging changes relate to your pain improvement.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United States